Indefinite Delivery Contract SPE2DB24D9224

The federal contract IDV award, valued at up to $499,999,999, is a single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is with the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and runs through December 31, 2025. Under this IDC, the DLA can issue firm fixed-price delivery orders for DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of DoD healthcare facilities worldwide. The delivered items include branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, covering a vast array of common and specialized medications such as flumazenil injections, prednisone tablets, epinephrine auto-injectors, oncology drugs, and specialty pharmaceuticals. The contract has no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for the DLA's pharmaceutical prime vendor programs supporting military medical facilities globally. The sample task orders provided demonstrate the delivery of specific pharmaceutical products, including Xtandi, Kyleena, Mirena, and Surgilube, to the DLA under this IDC.